Manufacturer
26 recalls in our database name Allergan, PLC. as the manufacturing or recalling firm.
Of the 26 recalls from Allergan, PLC. we have scored against our rubric, 3 (12%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 9 (35%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Allergan PLC is recalling Refresh Contacts Contact Lens Comfort Drops because the packages are missing the Instruction For Use insert. Consumers should stop using the product and contact the manufacturer.
Allergan is recalling Refresh Relieva Preservative-Free eye drops because the packaging is missing the instructions for use insert.
Allergan is recalling specific lots of Skin Medica Acne Treatment Lotion because the products failed potency tests at 12 and 24 months.
Allergan is recalling 8,555 Skin Medica Acne System kits nationwide because the products failed potency tests at 12 and 24 months.
Allergan is recalling Natrelle silicone breast implants because 2D barcodes may be unreadable by GS-1 scanners due to non-standard formatting.
Allergan is recalling Natrelle Inspira silicone-filled breast implants because 2D barcodes may be unreadable by GS-1 scanners due to formatting errors.
Allergan is recalling NATRELLE Resterilizable Sizers because 2D barcodes may be unreadable by GS-1 scanners due to non-standard formatting.
Allergan is recalling Natrelle saline-filled breast implants because 2D barcodes may be unreadable by GS-1 scanners due to formatting errors.
Allergan is recalling XEN Gel Stent implants because residual polishing compounds on the injector needle may transfer to the patient's eye, causing irritation or inflammation.
Allergan is recalling 4 million textured breast implants worldwide after FDA safety updates linked them to a higher incidence of anaplastic large cell lymphoma.
Allergan is recalling specific textured breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan is recalling Natrelle 133 tissue expanders due to FDA safety information regarding a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Allergan is recalling McGhan Croissant-Shaped Tissue Expanders because the FDA identified a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Allergan PLC is recalling McGhan BioDIMENSIONAL silicone-filled breast implants due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) associated with textured implants.
Allergan PLC is recalling Natrelle 133 tissue expanders due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) associated with textured breast implants.
Allergan PLC is recalling specific textured breast implants and tissue expanders due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan is recalling Natrelle tissue expanders because the FDA identified a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Allergan is recalling textured Natrelle Inspira breast implants and tissue expanders following FDA safety updates linking these devices to a higher incidence of anaplastic large cell lymphoma.
Allergan PLC is recalling specific textured breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan is recalling textured breast implants worldwide due to an increased risk of anaplastic large cell lymphoma (BIA-ALCL). Patients should consult their healthcare providers.
Allergan is recalling 4 million textured breast implants and tissue expanders worldwide due to an increased risk of anaplastic large cell lymphoma.
Allergan is recalling textured breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan PLC is recalling specific textured silicone-filled breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan PLC is recalling Natrelle textured breast implants and tissue expanders worldwide due to an increased risk of anaplastic large cell lymphoma.
Allergan is recalling 133,716 cartons of Ozurdex (dexamethasone) intravitreal implants because a silicone particulate was detected. The product was distributed to various accounts throughout the United States.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Allergan plc
Irish tax-registered pharmaceutical company
Source: Wikidata (Q906187), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.